Avoiding Patent Immortality for Self-Replicating Technologies


The Supreme Court in Quanta Computer, Inc. v. LG Electronics, Inc. reaffirmed the principle that the authorized sale of a patented item exhausts patent protection as to that particular item. However, it is unclear how the patent exhaustion/first sale doctrine should apply in the context of self-replicating technology, such as genetically modified or transgenic seed. Especially given the extreme results possible in cases such as Monsanto Co. v. Bowman, this article proposes that contract law rather than patent law should govern the patent holder’s rights in an object embodying self-replicating technology after an authorized sale.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Intellectual Property Updates, Science, Computers & Technology Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Yee Wah Chin, Ingram Yuzek Gainen Carroll & Bertolotti, LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »